EMBL Australia Group Leader
Join the SAIGENCI team of exceptionally motivated scientists as the EMBL Australia Group Leader in cancer research.
We invite applications from group leaders to join SAiGENCI as an EMBLAus group leader.
The South Australian immunoGENomics Cancer Institute (SAiGENCI) operates as an independent institute within the University of Adelaide and in alliance with the Central Adelaide Local Health Network (CALHN). SAiGENCI supports and promotes collaborations with other cancer research centres in Australia. SAiGENCI aims to develop the highest quality scientific program to achieve its chief goal of making discoveries to decrease the burden of cancer, by attracting and retaining brilliant biomedical and clinical researchers. The Institute will also have a global reach by collaborating with likeminded centres of excellence across the globe.
SAiGENCI will provide a focal point for cancer research in the South Australian Biomedical Precinct and through this, enable South Australian participation in the developing Australian network of cancer institutes, and national and international clinical trials partnerships. In so doing, SAiGENCI will help develop world-class and life-changing treatments and improve the outcomes of patients with cancer.
The overarching vision for SAiGENCI is to have a fundamentally positive impact on the conduct of cancer research, so that fewer patients develop cancer, and the lives of those with cancer is improved.
The Institute aims to become a hub for scientific discoveries and development of transformative technologies that will translate into improved clinical outcomes.
An important element of this approach is the creating and supporting the scientific leaders of tomorrow through implementation of the European Molecular Biology Laboratories Australia (EMBL Australia) framework. Australia is a member of the European Molecular Biology Laboratories (EMBL), Europe’s flagship life sciences institution.
This programme seeks to emulate the approach of EMBL group leader positions in European nodes in providing resourcing and mentoring to equip the brightest and most promising of researchers for future leadership in the discipline. The associate membership also gives Australia the opportunity to create an international profile for our life sciences research and introduce the world’s best young researchers to new scientific networks and the outstanding research infrastructure Australia has to offer.
Professor Christopher Sweeney
Message from the Dean
Over the past 137 years, the University of Adelaide has been at the forefront of health education and research. Our long and prestigious history began in 1885, with the establishment of Australia’s third medical school.
Our reputation and educational offerings continue to prosper, the creation of the South Australian immunoGENomics Cancer Institute (SAiGENCI) strengthens the University’s position as a world-class research-intensive institution. We have recruited some impressive talent to join SAiGENCI, and now, in conjunction with EMBLAus we are looking for additional outstanding research leaders to join our team. Through our groundbreaking research, learning, and practice, our faculty is transforming health sciences education, research and patient care—and making a real difference to the lives of individuals and communities around the world.
It truly is an exciting time to join our Faculty and SAiGENCI.
Professor Benjamin Kile
Executive Dean of Faculty of Health and Medical Sciences
About the role
EMBL Australia Group Leader in cancer research
SAiGENCI will emulate the approach of EMBL group leader positions in European nodes by providing resources and mentoring to equip the brightest and most promising of researchers for future leadership in the discipline. The associate membership also gives Australia the opportunity to create an international profile for our life sciences research and introduce the world’s best young researchers to new scientific networks and the outstanding research infrastructure Australia has to offer.
We are now seeking to recruit outstanding Research Group Leaders who will head up an independent research team undertaking research within one of four existing research themes:
The program will work on understanding the mechanisms underlying response and resistance to contemporary cancer therapies. It is envisaged that laboratory findings will be translated directly from bench to bedside through clinical trials.
Tumour Inflammation and Immunotherapy
The Tumour Inflammation and Immunotherapy program, led by Professor Brendan Jenkins, will aim to manipulate both innate and adaptive arms of the immune system, including augmentation of tumour antigenicity and modulation of the inflammatory response, as key strategies to suppress tumourigenesis. The program is seeking particular interest from leading researchers with expertise in NK and/or T cell-based immunotherapy or adaptive immunity. The cancer type to be targeted is not defined, with a tissue agnostic approach that has potential to apply to multiple cancers.
The Cancer Epigenetic program, led by Professor Jose Polo, combines Cancer, Reprogramming and Epigenetics, using expertise in cellular reprogramming, epigenetics, stem cell biology and the characterisation of rare cell populations. In the last 14 years there has been a revolution in this field, leading to an explosion in the use of reprogramming in potential cellular therapies. This process can inform and help in cancer biology research. Tools and analytical methods to facilitate the understanding of the epigenetic mechanism underpinning several tumorigenic processes will be developed, where epigenetic and reprogramming research will also allow the discovery of new targets and, ultimately, therapies.
Computational Systems Oncology
The expert computational systems biologist and Bioinformatics program, led by Professor Melissa Davis, will create a centre of research excellence in advanced computational systems biology, taking advantage of novel technologies and high-density data from the clinic and laboratory, to develop new methods and research programs that will form an integral part of all of the basic and translational research excellence at SAiGENCI. The team is proving to act as a catalyst for several important relationships in computing and data analysis, enhancing the existing strengths of the University through the Australian Institute for Machine Learning (AIML) and other partners at SAHMRI.
For a confidential discussion about the role, please contact:
Professor Christopher Sweeney
+61 8 8313 9595
To learn more about the role, please read the position description:
At the University of Adelaide, we embrace our role and purpose as a future-maker—for our state, our nation and our world.
We pursue meaningful change as we celebrate our proud history: applying proven values in the pursuit of contemporary educational and research excellence; meeting our local and global community’s evolving needs and challenges; and striving to prepare our graduates for their aspirations and the needs of the future workforce. We are recognised as one of Australia's most respected research-intensive universities.
SAiGENCI will be supported by the greater ecosystem of The University of Adelaide, a research-intensive institution, conducting work of the highest quality, as shown by >85% of its Fields of Research assessed in ERA 2018 being rated at 4 or 5, ‘above’ or ‘well above’ world standard respectively. The vision of the University is “to realise its purpose as a catalyst for knowledge creation and innovation, as an engine of social advancement, and as an active participant in the local, national and global economy.” The University’s key research priorities include attracting and retaining top talent, fast-tracking research career development, enhancing its PhD programs, promoting translation of research, collaborating with industry and peak industry bodies and improving support for researchers via enhanced systems, services and infrastructure. Initiatives targeting support to early and mid-career researchers are linked to career development pathways in partnership with faculties and schools to provide robust, long-term career opportunities for our rising stars, and strengthen research capacity in our academic workforce.
The whole-of-University FAME (Foci and Magnets of Excellence) Strategy in Healthy Societies supports the fundamentally important area of health and medical research and delivery, and builds on the growing success of our researchers in the Medical Research Future Fund; the establishment of SAiGENCI; and Government support for the new Bragg Comprehensive Cancer Centre as a partnership between the University, SAHMRI, the Central Adelaide Local Health Network and the Women’s and Children’s Health Network. In particular, attracting and retaining high-quality research teams in South Australia, and integrating academic and clinical research endeavours.
Our global partnerships program provides our researchers with access to some of the best international research groups and infrastructure, with joint research funding schemes, travel support, joint PhD programs, and other opportunities through major joint ventures with such partners. The University continues to make major investments in consolidated infrastructure platforms for key capabilities, and enhancing mission critical resources such as high-performance computing and bioinformatics. Our researchers are also assisted in their endeavours to translate fundamental research via support from our commercialisation and innovation units including Adelaide Enterprise, Research and Business Partnerships and ThincLab Adelaide.
About the University Research & Innovation
The University of Adelaide is an Equal Opportunity employer that is committed to being fair, equitable and sensitive to the diverse needs of its staff. Within the Faculty, we embrace diversity and welcome all the experiences’ that you’ll bring to the role.
About the Faculty of Health and Medical Sciences
The Faculty of Health and Medical Sciences fosters exciting, diverse and impactful health research. Our researchers conduct cutting edge, transformative research that provides new insights into human biology and delivers real health outcomes to our community.
Health-related research has vastly improved the lives of our community and contributed to the greater wellbeing of our society. Innovative technologies and novel scientific discoveries have led to new treatments, new ways of thinking and the development of new health policy.
Across the faculty, we conduct world-class fundamental, biomedical, translational and population health research that is consistently ranked in the top 1% of Universities internationally. Our research activities cover the life course, from conception through to ageing.
The faculty nurtures our students’ development with first-class, nationally recognised teaching. Our goal is to produce graduates capable of not only breaking new scientific ground, but inspiring others to compassionately and collaboratively enhance care throughout the world.
The COVID-19 pandemic has highlighted more than ever the importance of health and wellbeing. Health is about potential—the potential for humans to live well and thrive.
The next generation of health leaders have a unique opportunity to transform lives at a time when it is most needed: to help prevent disease, enhance wellbeing, and create stronger, healthier communities.
Central Adelaide Local Health Network (CALHN)
The Central Adelaide Local Health Network (CALHN) plays an important role in improving the health and wellbeing of South Australians. It delivers world-class integrated healthcare, and general and quaternary hospital services.
CALHN has a strong commitment to the delivery of clinical services in an environment that is supportive of, and informed by, research across all disciplines.
CALHN’s involvement as an alliance partner in SAiGENCI is fundamental to the institute’s approach to building strong collaborative links between clinical and research communities. This partnership will lead to improved treatment and care options for South Australians living with cancer.
Bragg Comprehensive Cancer Centre (BCCC)
SAiGENCI has already established close ties to the developing Bragg Comprehensive Cancer Centre (BCCC) which includes the recruitment of active clinician scientists to provide a real and tangible link between bench research and patients. The BCCC would join the emerging National Cancer Institutes (NCI) collaboration, with SAiGENCI playing the lead research role. SAiGENCI leadership and science will play a key role in helping build the clinical research capacity and rigour of the science of the clinical research enterprise.
Life in Adelaide
Adelaide—with our University at its beating heart—is consistently voted one of the world’s most liveable and affordable cities *.
Adelaide has a bustling, energetic city centre and is renowned for its festivals, cultural life and sporting events. With great shopping, beaches, a café culture and friendly residents, Adelaide offers a relaxed lifestyle with the convenience of city living.
A truly liveable city
Safe and relaxed, Adelaide is ranked as one of the worlds most liveable cities, when measured across stability, healthcare, culture and environment, education and infrastructure*.
Australia’s most affordable mainland city
With a cost of living up to 14% lower than Sydney and Melbourne*
South Australia's 1.3m population hail from over 120 different countries, creating a wonderful mix of cultures and influences. One in five South Australians were born overseas.
South Australia is also globally renowned for its premium wine regions, such as the Barossa Valley, McLaren Vale and the Coonawarra, beautiful sandy beaches, stunning and geologically significant Flinders Ranges,and the iconic Australian Outback.
South Australia has a Mediterranean climate, with warm, dry summers and mild winters.
|Summer||Dec - Feb||Mainly hot/dry||25 - 35℃|
|Autumn||Mar - May||Mainly dry||20 - 25℃|
|Winter||Jun - Aug||Cool and wet||10 - 15℃|
|Spring||Sept - Nov||Some rain||20 - 25℃|
* Economist Intelligence Unit Global Liveability Index 2021